Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-23

Clinical Trial Update: Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk [NA]

View source ↗

Summary

A clinical trial evaluating a digital behavioral therapy to reduce the risk of Type 2 Diabetes and liver disease, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: SIPPA Solutions INC | Conditions: Type 2 Diabetes, Prediabetes | NA | Status: NOT_YET_RECRUITING